Dr Fernanda Tavares Da Silva | Senior Director, Head Of Safety Evaluation And Risk Management
GlaxoSmithKline

Dr Fernanda Tavares Da Silva, Senior Director, Head Of Safety Evaluation And Risk Management, GlaxoSmithKline

Fernanda holds a Medical Doctor degree, with Postgraduate in Gynecology and Obstetrics from the Central University of Venezuela and has had over 12 years of clinical practice. Fernanda joined  GlaxoSmithKline Biologicals In March 2005, holding roles of increasing responsibility within Clinical Safety & Pharmacovigilance, where she has obtained a broad exposure across product lifecycle on a variety of prophylactic and therapeutic vaccines. Fernanda is currently serving as Head of Safety Evaluation & Risk Management of the Research & Development Center based in Belgium and over the past  years, she has  participated as active member of a variety of GSK vaccines Senior Advisory groups for safety-related topics and risk management strategies, in particular for Adjuvanted vaccines, Pregnancy Outcomes and Maternal Immunization.

Appearances:



April 17 Day 3 - 10 Co-conferences & Plenary @ 09:10

Safety monitoring of vaccines targeting special populations (e.g. elderly, maternal): Current challenges and approaches

last published: 21/Mar/19 15:25 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071